Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.miel.co.in | |
Market Cap | 17.40 Cr. | |
Enterprise Value(EV) | 17.40 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.09 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 386.59 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 82.08 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 15.96 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.21 | Calculated using Price: 35.33 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.49 Cr. | 4,924,070 Shares |
FaceValue | 10 | |
About Macro International Ltd. | ||
Macro International has been the leading manufacturer and supplier of neoprene sheets, neoprene rolls, and neoprene products in North America. With over three decades of company history and continued excellence. |
1 Day |
|
|
1 Week |
|
|
1 Month |
|
+4.99% |
3 Month |
|
+10.23% |
6 Month |
|
+15.12% |
1 Year |
|
+36.94% |
2 Year |
|
+542.36% |
5 Year |
|
+284.44% |
10 Year |
|
+77.09% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3.57 | 0.16 | 0.10 | -0.13 | -1.57 | -0.54 | 0.12 | -0.33 | 0.32 | |
Return on Capital Employed (%) | 0.97 | 0.36 | 0.20 | -0.09 | -1.44 | -0.54 | 0.16 | -0.33 | 0.62 | |
Return on Assets (%) | 3.35 | 0.15 | 0.10 | -0.12 | -1.53 | -0.53 | 0.11 | -0.32 | 0.22 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
Non Curr. Liab. | 0 | 0 | 0 | 5 | |||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | |
Non Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 4 | |
Curr. Assets | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 0 | 6 | 8 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 3 | 6 | |||||||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 7 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -6 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Cash Fr. Inv. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Finan. | 1 | ||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | ||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 08 Dec 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 08Th December 2023 At 05.00 P.M. Dear Sir/Madam This is to inform that Board of Directors of the Company in its meeting held on Friday 08th December 2023 at 05.00 P.M. at the Corporate office of the company i.e. 304 3rd Floor Babukhan Estate Basheerbagh Hyderabad Telangana 500001 has taken following decisions:1. Approved to Change the name of the Company from MACRO INTERNATIONAL LIMITED to ASTAL HEALTHCARE LIMITED or any other name as may be available with ROC subject to approval of Registrar of Companies Utter Pradesh and subject to approval of Stock Exchanges i.e. the BSE Limited on which the securities are Listed and subject to approval of Shareholders of the Company in the ensuing General Meeting and subject to approval of any other authority as may be required;and other matters. |
Thu, 30 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aceso Research Labs LLP |
Thu, 30 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aceso Research Labs LLP |
Mon, 04 Dec 2023 |
|
|
|
|
|